Cargando…
Erratum to: ‘Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program’
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877730/ https://www.ncbi.nlm.nih.gov/pubmed/27222638 http://dx.doi.org/10.1186/s12959-016-0085-1 |
| _version_ | 1782433432971771904 |
|---|---|
| author | Yamada, Norikazu Hirayama, Atsushi Maeda, Hideaki Sakagami, Satoru Shikata, Hiroo Prins, Martin H. Lensing, Anthonie W. A. Kato, Masaharu Onuma, Junichi Miyamoto, Yuki Iekushi, Kazuma Kajikawa, Mariko |
| author_facet | Yamada, Norikazu Hirayama, Atsushi Maeda, Hideaki Sakagami, Satoru Shikata, Hiroo Prins, Martin H. Lensing, Anthonie W. A. Kato, Masaharu Onuma, Junichi Miyamoto, Yuki Iekushi, Kazuma Kajikawa, Mariko |
| author_sort | Yamada, Norikazu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4877730 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-48777302016-05-25 Erratum to: ‘Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program’ Yamada, Norikazu Hirayama, Atsushi Maeda, Hideaki Sakagami, Satoru Shikata, Hiroo Prins, Martin H. Lensing, Anthonie W. A. Kato, Masaharu Onuma, Junichi Miyamoto, Yuki Iekushi, Kazuma Kajikawa, Mariko Thromb J Erratum BioMed Central 2016-05-23 /pmc/articles/PMC4877730/ /pubmed/27222638 http://dx.doi.org/10.1186/s12959-016-0085-1 Text en © Yamada et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Erratum Yamada, Norikazu Hirayama, Atsushi Maeda, Hideaki Sakagami, Satoru Shikata, Hiroo Prins, Martin H. Lensing, Anthonie W. A. Kato, Masaharu Onuma, Junichi Miyamoto, Yuki Iekushi, Kazuma Kajikawa, Mariko Erratum to: ‘Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program’ |
| title | Erratum to: ‘Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program’ |
| title_full | Erratum to: ‘Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program’ |
| title_fullStr | Erratum to: ‘Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program’ |
| title_full_unstemmed | Erratum to: ‘Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program’ |
| title_short | Erratum to: ‘Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program’ |
| title_sort | erratum to: ‘oral rivaroxaban for japanese patients with symptomatic venous thromboembolism – the j-einstein dvt and pe program’ |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877730/ https://www.ncbi.nlm.nih.gov/pubmed/27222638 http://dx.doi.org/10.1186/s12959-016-0085-1 |
| work_keys_str_mv | AT yamadanorikazu erratumtooralrivaroxabanforjapanesepatientswithsymptomaticvenousthromboembolismthejeinsteindvtandpeprogram AT hirayamaatsushi erratumtooralrivaroxabanforjapanesepatientswithsymptomaticvenousthromboembolismthejeinsteindvtandpeprogram AT maedahideaki erratumtooralrivaroxabanforjapanesepatientswithsymptomaticvenousthromboembolismthejeinsteindvtandpeprogram AT sakagamisatoru erratumtooralrivaroxabanforjapanesepatientswithsymptomaticvenousthromboembolismthejeinsteindvtandpeprogram AT shikatahiroo erratumtooralrivaroxabanforjapanesepatientswithsymptomaticvenousthromboembolismthejeinsteindvtandpeprogram AT prinsmartinh erratumtooralrivaroxabanforjapanesepatientswithsymptomaticvenousthromboembolismthejeinsteindvtandpeprogram AT lensinganthoniewa erratumtooralrivaroxabanforjapanesepatientswithsymptomaticvenousthromboembolismthejeinsteindvtandpeprogram AT katomasaharu erratumtooralrivaroxabanforjapanesepatientswithsymptomaticvenousthromboembolismthejeinsteindvtandpeprogram AT onumajunichi erratumtooralrivaroxabanforjapanesepatientswithsymptomaticvenousthromboembolismthejeinsteindvtandpeprogram AT miyamotoyuki erratumtooralrivaroxabanforjapanesepatientswithsymptomaticvenousthromboembolismthejeinsteindvtandpeprogram AT iekushikazuma erratumtooralrivaroxabanforjapanesepatientswithsymptomaticvenousthromboembolismthejeinsteindvtandpeprogram AT kajikawamariko erratumtooralrivaroxabanforjapanesepatientswithsymptomaticvenousthromboembolismthejeinsteindvtandpeprogram |